These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2427494)

  • 21. Recovery from potentially lethal damage induced by spirohydantoin mustard on 9L cells in vitro.
    Bertrand M; Deen DF; Hoshino T; Knebel K
    Cancer Treat Rep; 1980; 64(8-9):889-95. PubMed ID: 7448827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
    Harrison JH; Hoyt DG; Lazo JS
    Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of mammalian cells to bleomycin-induced potentially lethal and sublethal damage.
    Barranco SC; Humphrey RM
    Prog Biochem Pharmacol; 1976; 11():78-92. PubMed ID: 63973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery from lethal and mutagenic damage during postirradiation holding and low-dose-rate irradiations of cultured hamster cells.
    Thacker J; Stretch A
    Radiat Res; 1983 Nov; 96(2):380-92. PubMed ID: 6647766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethanol-induced cell sensitization to bleomycin cytotoxicity and the inhibition of recovery from potentially lethal damage.
    Mizuno S
    Cancer Res; 1981 Oct; 41(10):4111-4. PubMed ID: 6169432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of cells from induced, potentially lethal damage.
    Hahn GM
    Cancer Treat Rep; 1976 Dec; 60(12):1791-8. PubMed ID: 67891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action.
    Ojo-Amaize EA; Nchekwube EJ; Cottam HB; Bai R; Verdier-Pinard P; Kakkanaiah VN; Varner JA; Leoni L; Okogun JI; Adesomoju AA; Oyemade OA; Hamel E
    Cancer Res; 2002 Jul; 62(14):4007-14. PubMed ID: 12124334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased glutathione level is not involved in enhanced bleomycin sensitivity in cisplatin-resistant 2780CP cells.
    Tanaka T; Kurokawa H; Matsuno K; Matsumoto S; Hayashida Y
    Anticancer Res; 2008; 28(5A):2663-8. PubMed ID: 19035292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth-related glycogen levels of human intestine carcinoma cell lines grown in vitro and in vivo in nude mice.
    Rousset M; Dussaulx E; Chevalier G; Zweibaum A
    J Natl Cancer Inst; 1980 Nov; 65(5):885-9. PubMed ID: 6933258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
    Adams EG; Crampton SL; Bhuyan BK
    Cancer Res; 1981 Dec; 41(12 Pt 1):4981-7. PubMed ID: 6458356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repair of potentially lethal damage in unfed plateau phase cultures of Ehrlich ascites tumour cells. II. Monolayer cultures.
    Iliakis G
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Jun; 37(6):591-600. PubMed ID: 6998889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
    Bhuyan BK; Blowers CL; Crampton SL; Shugars KD
    Cancer Res; 1981 Jan; 41(1):18-24. PubMed ID: 7448758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level.
    Smets LA; Homan-Blok J
    Cancer Res; 1985 Jul; 45(7):3113-7. PubMed ID: 4005848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice.
    Wang L; Cui Y; Lord BI; Roberts SA; Potten CS; Hendry JH; Scott D
    Radiat Res; 1996 Sep; 146(3):259-66. PubMed ID: 8752303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery.
    Norum OJ; Gaustad JV; Angell-Petersen E; Rofstad EK; Peng Q; Giercksky KE; Berg K
    Photochem Photobiol; 2009; 85(3):740-9. PubMed ID: 19076314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and cell cycle kinetics of a human squamous cell carcinoma in nude mice and in vitro.
    Meck RA; Ingram M; Meck JM; McCullough JL; Wu MC; Yunis AA
    Cancer Res; 1981 Mar; 41(3):1076-85. PubMed ID: 7193083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose fractionation does not prevent repair of potentially lethal damage induced by bleomycin (NSC-125066) in vivo.
    Twentyman PR
    Cancer Treat Rep; 1976 Mar; 60(3):259-60. PubMed ID: 57001
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
    Harrison JH; Lazo JS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin.
    Miller RA; Woodburn KW; Fan Q; Lee I; Miles D; Duran G; Sikic B; Magda D
    Clin Cancer Res; 2001 Oct; 7(10):3215-21. PubMed ID: 11595717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.